Compounds > eriodictyol
Page last updated: 2024-08-21

eriodictyol and galangin

eriodictyol has been researched along with galangin in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's0 (0.00)29.6817
2010's7 (63.64)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Habtemariam, S1
Ash, K; Grohmann, K; Manthey, CL; Manthey, JA; Montanari, A1
Amić, D; Lucić, B1
Itoh, T; Sakakibara, H; Shimoi, K; Takemura, H; Yamamoto, K1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Chin, YW; Han, SY; Kong, JY1
Bilia, AR; Carta, F; Ceruso, M; Karioti, A; Supuran, CT1
Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM1
Ding, H; Dong, H; Hou, Z; Luo, C; Min, W; Qi, L; Wang, L; Xie, S; Yang, P; Yuan, K; Zhang, F1
Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC1
Kang, Y; Kim, BG; Kim, S; Lee, Y; Yoon, Y1

Other Studies

11 other study(ies) available for eriodictyol and galangin

ArticleYear
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
    Journal of natural products, 1997, Volume: 60, Issue:8

    Topics: Animals; Apoptosis; Drug Synergism; Flavonoids; Mice; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1997
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
    Journal of natural products, 1999, Volume: 62, Issue:3

    Topics: Citrus; Cyclic AMP; Flavonoids; Humans; In Vitro Techniques; Lipopolysaccharides; Monocytes; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha

1999
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
    Bioorganic & medicinal chemistry, 2010, Jan-01, Volume: 18, Issue:1

    Topics: Flavonoids; Free Radical Scavengers; Models, Biological; Quantitative Structure-Activity Relationship; Quantum Theory; Software; Thermodynamics

2010
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
    Bioorganic & medicinal chemistry, 2010, Sep-01, Volume: 18, Issue:17

    Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Flavonoids as receptor tyrosine kinase FLT3 inhibitors.
    Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6

    Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavonoids; fms-Like Tyrosine Kinase 3; Humans; Luteolin; Protein Kinase Inhibitors

2013
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
    Bioorganic & medicinal chemistry, 2015, Nov-15, Volume: 23, Issue:22

    Topics: Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isoenzymes; Kinetics; Phenol; Protein Binding; Quercus; Salvia; Structure-Activity Relationship

2015
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
    Journal of natural products, 2015, Nov-25, Volume: 78, Issue:11

    Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship

2015
Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7.
    Bioorganic & medicinal chemistry, 2020, 04-01, Volume: 28, Issue:7

    Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Survival; Computational Chemistry; Computer Simulation; Drug Discovery; Escherichia coli; Histone-Lysine N-Methyltransferase; Humans; Molecular Structure; Protein Binding; Protein Conformation; Structure-Activity Relationship

2020
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
    Journal of natural products, 2020, 05-22, Volume: 83, Issue:5

    Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure

2020
Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
    Bioorganic & medicinal chemistry letters, 2017, 02-01, Volume: 27, Issue:3

    Topics: 3-Phosphoinositide-Dependent Protein Kinases; Binding Sites; Flavones; Flavonoids; Flavonols; Liposomes; Molecular Docking Simulation; Phosphatidylinositol Phosphates; Pleckstrin Homology Domains; Protein Binding; Quantitative Structure-Activity Relationship

2017